Limb Salvage in Pediatrics with Malignant Bone Tumors:Team Approach to Orthopedic Oncology
Pediatric limb salvage necessitates collaboration of multi-disciplinary team approach; members are orthopedic oncologist, pediatric oncologist, radiologist, pathologist, physiotherapist, and psychotherapist. Limb-salvage choices fall into two principal categories, biological reconstruction as well as endoprosthetic arthroplasty, each of which has functional and technical concerns that are fundamental to determine the optimal management option. Limb-salvage surgery in pediatrics has unique challenges, with precise planning to assure the maintenance of limb-length equality with durable construction for long-term function into adulthood. Limb salvage can achieve satisfactory oncological and functional results and quality of life as compared with amputation. Improvements in biological reconstructive methods, as well as endoprosthetic design, allow effective limb-salvage choices after oncological resections in pediatrics that are ideally adjusted to the patient’s unique functional needs.
1.Cortes EP, Holland JF, Wang JJ, Sinks LF, Blom J, Senn H, et al. Amputation and adriamycin in primary osteosarcoma. N Engl J Med 1974;291:998–1000. [CrossRef]
2. Woodruff M. The challenge of osteosarcoma. Ann R Coll Surg Engl 1969;44:299–307.
3. Campanacci M, Laus M. Local recurrence after amputation for osteosarcoma. J Bone Joint Surg Br 1980;62-b:201–7. [CrossRef]
4. Price CH, Zhuber K, Salzer-Kuntschik M, Salzer M, Willert HG, Immenkamp M, et al. Osteosarcoma in children. A study of 125 cases. J Bone Joint Surg Br 1975;57:341–5. [CrossRef]
5. Campanacci M, Cervellati G. Osteosarcoma: A review of 345 cases. Ital J Orthop Traumatol 1975;1:5–22.
6. Sinks LF, Mindell ER. Chemotherapy of osteosarcoma. Clin Orthop Relat Res 1975:101–4. [CrossRef]
7. Jaffe N. The potential for an improved prognosis with chemotherapy in osteogenic sarcoma. Clin Orthop Relat Res 1975:111–8. [CrossRef]
8. van Oosterwijk JG, Anninga JK, Gelderblom H, Cleton-Jansen AM, Bovee JV. Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma. Hematol Oncol Clin North Am 2013;27:1021–48. [CrossRef]
9. Cohen IJ, Kaplinsky C, Katz K, Mor C, Goshen Y, Yaniv Y, et al. Improved results in osteogenic sarcoma 1973-79 vs. 1980- 86: analysis of results from a single center. Isr J Med Sci 1993;29:27–9.
10. Simon MA, Aschliman MA, Thomas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am 1986;68:1331–7.
11. Eilber FR, Mirra JJ, Grant TT, Weisenburger T, Morton DL. Is amputation necessary for sarcomas? A seven-year experience with limb salvage. Ann Surg 1980;192:431–8. [CrossRef]
12. Rougraff BT, Simon MA, Kneisl JS, Greenberg DB, Mankin HJ. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am 1994;76:649–56. [CrossRef]
13. Choong PF, Sim FH. Limb-sparing surgery for bone tumors: new developments. Semin Surg Oncol 1997;13:64–9. [CrossRef]
14. Carty CP, Bennett MB, Dickinson IC, Steadman P. Assessment of kinematic and kinetic patterns following limb salvage procedures for bone sarcoma. Gait Posture 2009;30:547–51.
15. DiCaprio MR, Friedlaender GE. Malignant bone tumors: limb sparing versus amputation. J Am Acad Orthop Surg 2003;11:25–37. [CrossRef]
16. Zahlten-Hinguranage A, Bernd L, Ewerbeck V, Sabo D. Equal quality of life after limb-sparing or ablative surgery for lower extremity sarcomas. Br J Cancer 2004;91:1012–4. [CrossRef]
17. Ottaviani G, Robert RS, Huh WW, Palla S, Jaffe N. Sociooccupational and physical outcomes more than 20 years after the diagnosis of osteosarcoma in children and adolescents: limb salvage versus amputation. Cancer 2013;119:3727–36.
18. Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG. Osteosarcoma in children 5 years of age or younger at initial diagnosis. Pediatr Blood Cancer 2010;55:285–9. [CrossRef]
19. Varan A, Yazici N, Aksoy C, Gedikoglu G, Yalcin B, Akyuz C, et al. Treatment results of pediatric osteosarcoma: twenty-year experience. J Pediatr Orthop 2007;27:241–6.
20. Hudson MM, Tyc VL, Cremer LK, Luo X, Li H, Rao BN, et al. Patient satisfaction after limb-sparing surgery and amputation for pediatric malignant bone tumors. J Pediatr Oncol Nurs 1998;15:60–9; discussion 70–1. [CrossRef]
21. Henderson ER, Pepper AM, Marulanda G, Binitie OT, Cheong D, Letson GD. Outcome of lower-limb preservation with an expandable endoprosthesis after bone tumor resection in children. J Bone Joint Surg Am 2012;94:537–47. [CrossRef]
22. Dominkus M, Krepler P, Schwameis E, Windhager R, Kotz R. Growth prediction in extendable tumor prostheses in children. Clin Orthop Relat Res 2001:212–20. [CrossRef]
23. Meswania JM, Taylor SJ, Blunn GW. Design and characterization of a novel permanent magnet synchronous motor used in a growing prosthesis for young patients with bone cancer. Proc Inst Mech Eng H 2008;222:393–402. [CrossRef]
24. Gitelis S, Neel MD, Wilkins RM, Rao BN, Kelly CM, Yao TK. The use of a closed expandable prosthesis for pediatric sarcomas. Chir Organi Mov 2003;88:327–33.
25. Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. J Clin Oncol 2015;33:3029–35. [CrossRef]
26. Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther 2018;18:39–50. [CrossRef]
27. Kridis WB, Toumi N, Chaari H, Khanfir A, Ayadi K, Keskes H, et al. A Review of Ewing Sarcoma Treatment: Is it Still a Subject of Debate? Rev Recent Clin Trials 2017;12:19–23. [CrossRef]
28. Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley MC, et al. Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. J Clin Oncol 2015;33:3036–46. [CrossRef]
29. Wittig JC, Bickels J, Priebat D, Jelinek J, Kellar-Graney K, Shmookler B, et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician 2002;65:1123–32.
30. Biazzo A, De Paolis M. Multidisciplinary approach to osteosarcoma. Acta Orthop Belg 2016;82:690–8.
31. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 1999;341:342–52.
32. Lewis VO, Morris CD, Parsons TW, 3rd. Malignant and benign bone tumors that you are likely to see. Instr Course Lect 2013;62:535–49.
33. Clayer M. Many faces of osteosarcoma on plain radiographs. ANZ J Surg 2015;85:22–6. [CrossRef]
34. Rosenberg ZS, Lev S, Schmahmann S, Steiner GC, Beltran J, Present D. Osteosarcoma: subtle, rare, and misleading plain film features. AJR Am J Roentgenol 1995;165:1209–14.
35. Spina V, Montanari N, Romagnoli R. Malignant tumors of the osteogenic matrix. Eur J Radiol 1998;27 Suppl 1:S98–109.
36. Simpson E, Brown HL. Understanding osteosarcomas. Jaapa 2018;31:15–9. [CrossRef]
37. Saifuddin A, Sharif B, Gerrand C, Whelan J. The current status of MRI in the pre-operative assessment of intramedullary conventional appendicular osteosarcoma. Skeletal Radiol 2019;48:503–16. [CrossRef]
38. Picci P. Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis 2007;2:6. [CrossRef]
39. Panzica M, Luke U, Mommsen P, Krettek C. [Biopsy and approach routes for bone tumors. Where and how much is sufficient?]. Unfallchirurg 2014;117:501–9. [CrossRef]
40. Gambarotti M, Dei Tos AP, Vanel D, Picci P, Gibertoni D, Klein MJ, et al. Osteoblastoma-like osteosarcoma: high-grade or low-grade osteosarcoma? Histopathology 2019;74:494–503.
41. Puls F, Niblett AJ, Mangham DC. Molecular pathology of bone tumours: diagnostic implications. Histopathology 2014;64:461–76. [CrossRef]
42. Hayashi K, Tsuchiya H, Yamamoto N, Shirai T, Nishida H, Takeuchi A, et al. Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases. Int J Clin Oncol 2014;19:731– 8. [CrossRef]
43. Meyers PA. Systemic therapy for osteosarcoma and Ewing sarcoma. Am Soc Clin Oncol Educ Book 2015:e644–7.
44. Rosen G, Murphy ML, Huvos AG, Gutierrez M, Marcove RC. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 1976;37:1–11. [CrossRef]
45. Jimmy R, Stern C, Lisy K, White S. Effectiveness of mifamurtide in addition to standard chemotherapy for high-grade osteosarcoma: a systematic review. JBI Database System Rev Implement Rep 2017;15:2113–52. [CrossRef]
46. Yang Y, Han L, He Z, Li X, Yang S, Yang J, et al. Advances in limb salvage treatment of osteosarcoma. J Bone Oncol 2018;10:36– 40. [CrossRef]
47. Ma ZT, Li HG. Limb-salvage for osteosarcoma. Chin Med J (Engl) 1994;107:854–7.
48. Grimer RJ, Aydin BK, Wafa H, Carter SR, Jeys L, Abudu A, et al. Very long-term outcomes after endoprosthetic replacement for malignant tumours of bone. Bone Joint J 2016;98-B:857– 64. [CrossRef]
49. Myers GJ, Abudu AT, Carter SR, Tillman RM, Grimer RJ. Endoprosthetic replacement of the distal femur for bone tumours: long-term results. J Bone Joint Surg Br 2007;89:521–6.
50. Funovics PT, Bucher F, Toma CD, Kotz RI, Dominkus M. Treatment and outcome of parosteal osteosarcoma: bio-logical versus endoprosthetic reconstruction. J Surg Oncol 2011;103:782–9. [CrossRef]
51. San-Julian M, Vazquez-Garcia B. Biological Reconstruction in Bone Sarcomas: Lessons from Three Decades of Experience. Orthop Surg 2016;8:111–21. [CrossRef]
52. Bielack SS, Hecker-Nolting S, Blattmann C, Kager L. Advances in the management of osteosarcoma. F1000Res 2016;5:2767.
53. Campanacci DA, Puccini S, Caff G, Beltrami G, Piccioli A, Innocenti M, et al. Vascularised fibular grafts as a salvage procedure in failed intercalary reconstructions after bone tumour resection of the femur. Injury 2014;45:399–404. [CrossRef]
54. Zhang C, Hu J, Zhu K, Cai T, Ma X. Survival, complications and functional outcomes of cemented megaprostheses for high-grade osteosarcoma around the knee. Int Orthop 2018;42:927–38. [CrossRef]
55. Kamal AF, Rubiansyah P. Clinical outcome of various limb salvage surgeries in osteosarcoma around knee: Megaprosthesis, extracorporeal irradiation and resection arthrodesis. Ann Med Surg (Lond) 2019;42:14–8. [CrossRef]
56. Muramatsu K, Ihara K, Hashimoto T, Seto S, Taguchi T. Combined use of free vascularised bone graft and extracorporeally-irradiated autograft for the reconstruction of massive bone defects after resection of malignant tumour. J Plast Reconstr Aesthet Surg 2007;60:1013–8. [CrossRef]
57. Halim AS, Chai SC, Wan Ismail WF, Wan Azman WS, Mat Saad AZ, Wan Z. Long-term outcome of free fibula osteocutaneous flap and massive allograft in the reconstruction of long bone defect. J Plast Reconstr Aesthet Surg 2015;68:1755–62.
58. Estrella EP, Wang EH. A Comparison of Vascularized Free Fibular Flaps and Nonvascularized Fibular Grafts for Reconstruction of Long Bone Defects after Tumor Resection. J Reconstr Microsurg 2017;33:194–205. [CrossRef]
59. Bus MP, van de Sande MA, Taminiau AH, Dijkstra PD. Is there still a role for osteoarticular allograft reconstruction in musculoskeletal tumour surgery? a long-term follow-up study of 38 patients and systematic review of the literature. Bone Joint J 2017;99-B:522–30. [CrossRef]
60. Wilson RJ, Sulieman LM, VanHouten JP, Halpern JL, Schwartz HS, Devin CJ, et al. Cost-utility of osteoarticular allograft versus endoprosthetic reconstruction for primary bone sarcoma of the knee: A markov analysis. J Surg Oncol 2017;115:257–65.
61. Fu J, Guo Z, Wang Z, Li X, Fan H, Li J, et al. [Use of four kinds of three-dimensional printing guide plate in bone tumor resection and reconstruction operation]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2014;28:304–8.
62. Muscolo DL, Ayerza MA, Aponte-Tinao LA, Ranalletta M. Partial epiphyseal preservation and intercalary allograft reconstruction in high-grade metaphyseal osteosarcoma of the knee. J Bone Joint Surg Am 2005;87 Suppl 1(Pt 2):226–36. [CrossRef]
63. Weitao Y, Qiqing C, Songtao G, Jiaqiang W. Epiphysis preserving operations for the treatment of lower limb malignant bone tumors. Eur J Surg Oncol 2012;38:1165–70. [CrossRef]
64. Buecker PJ, Berenstein M, Gebhardt MC, Hornicek FJ, Mankin HJ. Locking versus standard plates for allograft fixation after tumor resection in children and adolescents. J Pediatr Orthop 2006;26:680–5. [CrossRef]
65. Mei J, Ni M, Jia GY, Chen YX, Zhu XZ. Intermittent internal fixation with a locking plate to preserve epiphyseal growth function during limb-salvage surgery in a child with osteosarcoma of the distal femur: a case report. Medicine (Baltimore) 2015;94:e830. [CrossRef]
66. Canadell J, Forriol F, Cara JA. Removal of metaphyseal bone tumours with preservation of the epiphysis. Physeal distraction before excision. J Bone Joint Surg Br 1994;76:127–32.
67. Panagopoulos GN, Mavrogenis AF, Mauffrey C, Lesensky J, Angelini A, Megaloikonomos PD, et al. Intercalary reconstructions after bone tumor resections: a review of treatments. Eur J Orthop Surg Traumatol 2017;27:737–46. [CrossRef]
68. Ortiz-Cruz E, Gebhardt MC, Jennings LC, Springfield DS, Mankin HJ. The results of transplantation of intercalary allografts after resection of tumors. A long-term follow-up study. J Bone Joint Surg Am 1997;79:97–106. [CrossRef]
69. Mankin HJ, Gebhardt MC, Jennings LC, Springfield DS, Tomford WW. Long-term results of allograft replacement in the management of bone tumors. Clin Orthop Relat Res 1996:86–97.
70. Bakri K, Stans AA, Mardini S, Moran SL. Combined massive allograft and intramedullary vascularized fibula transfer: the capanna technique for lower-limb reconstruction. Semin Plast Surg 2008;22:234–41. [CrossRef]
71. Houdek MT, Wagner ER, Stans AA, Shin AY, Bishop AT, Sim FH, et al. What Is the Outcome of Allograft and Intramedullary Free Fibula (Capanna Technique) in Pediatric and Adolescent Patients With Bone Tumors? Clin Orthop Relat Res 2016;474:660–8. [CrossRef]
72. Betz M, Dumont CE, Fuchs B, Exner GU. Physeal distraction for joint preservation in malignant metaphyseal bone tumors in children. Clin Orthop Relat Res 2012;470:1749–54. [CrossRef]
73. Yang Z, Tao H, Ye Z, Jin L, Lin N, Yang D. Bone transport for reconstruction of large bone defects after tibial tumor resection: a report of five cases. J Int Med Res 2018;46:3219–25.
74. Watanabe K, Tsuchiya H, Yamamoto N, Shirai T, Nishida H, Hayashi K, et al. Over 10-year follow-up of functional outcome in patients with bone tumors reconstructed using distraction osteogenesis. J Orthop Sci 2013;18:101–9. [CrossRef]
75. Xu SF, Yu XC, Xu M, Chen X. Successful management of a childhood osteosarcoma with epiphysiolysis and distraction osteogenesis. Curr Oncol 2014;21:e658–62. [CrossRef]
76. He X, Zhang HL, Hu YC. Limb Salvage by Distraction Osteogenesis for Distal Tibial Osteosarcoma in a Young Child: A Case Report. Orthop Surg 2016;8:253–6. [CrossRef]
77. Zhang Y, Yang Z, Li X, Chen Y, Zhang S, Du M, et al. Custom prosthetic reconstruction for proximal tibial osteosarco-ma with proximal tibiofibular joint involved. Surg Oncol 2008;17:87–95. [CrossRef]
78. Batta V, Coathup MJ, Parratt MT, Pollock RC, Aston WJ, Cannon SR, et al. Uncemented, custom-made, hydroxyapatite-coated collared distal femoral endoprostheses: up to 18 years' followup. Bone Joint J 2014;96-B:263–9. [CrossRef]
79. Schwartz AJ, Kabo JM, Eilber FC, Eilber FR, Eckardt JJ. Cemented distal femoral endoprostheses for musculoskeletal tumor: improved survival of modular versus custom implants. Clin Orthop Relat Res 2010;468:2198–210. [CrossRef]
80. Neel MD, Heck R, Britton L, Daw N, Rao BN. Use of a smooth press-fit stem preserves physeal growth after tumor resection. Clin Orthop Relat Res 2004:125–8. [CrossRef]
81. Li Y, Sun Y, Shan HC, Niu XH. Comparative Analysis of Early Follow-up of Biologic Fixation and Cemented Stem Fixation for Femoral Tumor Prosthesis. Orthop Surg 2019;11:451–9.
82. Ilyas I, Pant R, Kurar A, Moreau PG, Younge DA. Modular megaprosthesis for proximal femoral tumors. Int Orthop 2002;26:170–3. [CrossRef]
83. Natarajan MV, Balasubramanian N, Jayasankar V, Sameer M. Endoprosthetic reconstruction using total femoral custom mega prosthesis in malignant bone tumours. Int Orthop 2009;33:1359–63. [CrossRef]
84. Natarajan MV, Sivaseelam A, Ayyappan S, Bose JC, Sampath Kumar M. Distal femoral tumours treated by resection and custom mega-prosthetic replacement. Int Orthop 2005;29:309–13.
85. Ruggieri P, Mavrogenis AF, Pala E, Romantini M, Manfrini M, Mercuri M. Outcome of expandable prostheses in children. J Pediatr Orthop 2013;33:244–53. [CrossRef]
86. Grimer RJ, Belthur M, Carter SR, Tillman RM, Cool P. Extendible replacements of the proximal tibia for bone tumours. J Bone Joint Surg Br 2000;82:255–60. [CrossRef]
87. Morris CD, Wustrack RL, Levin AS. Limb-Salvage Options in Growing Children with Malignant Bone Tumors of the Lower Extremity: A Critical Analysis Review. JBJS Rev 2017;5:e7.
88. Saghieh S, Abboud MR, Muwakkit SA, Saab R, Rao B, Haidar R. Seven-year experience of using Repiphysis expandable prosthesis in children with bone tumors. Pediatr Blood Cancer 2010;55:457–63. [CrossRef]
89. Picardo NE, Blunn GW, Shekkeris AS, Meswania J, Aston WJ, Pollock RC, et al. The medium-term results of the Stanmore non-invasive extendible endoprosthesis in the treatment of paediatric bone tumours. J Bone Joint Surg Br 2012;94:425– 30. [CrossRef]
90. Cipriano CA, Gruzinova IS, Frank RM, Gitelis S, Virkus WW. Frequent complications and severe bone loss associated with the repiphysis expandable distal femoral prosthesis. Clin Orthop Relat Res 2015;473:831–8. [CrossRef]
91. Staals EL, Colangeli M, Ali N, Casanova JM, Donati DM, Manfrini M. Are Complications Associated With the Repiphysis((R)) Expandable Distal Femoral Prosthesis Acceptable for Its Continued Use? Clin Orthop Relat Res 2015;473:3003–13. [CrossRef]
92. Dotan A, Dadia S, Bickels J, Nirkin A, Flusser G, Issakov J, et al. Expandable endoprosthesis for limb-sparing surgery in children: long-term results. J Child Orthop 2010;4:391–400.
93. Merkel KD, Gebhardt M, Springfield DS. Rotationplasty as a reconstructive operation after tumor resection. Clin Orthop Relat Res 1991:231–6. [CrossRef]
94. Winkelmann WW. Rotationplasty. Orthop Clin North Am 1996;27:503–23.